Assessing the psychedelic "after-glow" in ayahuasca users: Post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index; none of the 77 sources its claims cite is checked for support yet.
Abstract
Background: Ayahuasca is a plant tea containing the psychedelic 5-HT2A agonist N,N-dimethyltryptamine and harmala monoamine-oxidase inhibitors. Acute administration leads to neurophysiological modifications in brain regions of the default mode network, purportedly through a glutamatergic mechanism. Post-acutely, ayahuasca potentiates mindfulness capacities in volunteers and induces rapid and sustained antidepressant effects in treatment-resistant patients. However, the mechanisms underlying these fast and maintained effects are poorly understood. Here, we investigated in an open-label uncontrolled study in 16 healthy volunteers ayahuasca-induced post-acute neurometabolic and connectivity modifications and their association with mindfulness measures. Methods: Using 1H-magnetic resonance spectroscopy and functional connectivity, we compared baseline and post-acute neurometabolites and seed-to-voxel connectivity in the posterior and anterior cingulate cortex after a single ayahuasca dose. Results: Magnetic resonance spectroscopy showed post-acute reductions in glutamate+glutamine, creatine, and N-acetylaspartate+N-acetylaspartylglutamate in the posterior cingulate cortex. Connectivity was increased between the posterior cingulate cortex and the anterior cingulate cortex, and between the anterior cingulate cortex and limbic structures in the right medial temporal lobe. Glutamate+glutamine reductions correlated with increases in the "nonjudging" subscale of the Five Facets Mindfulness Questionnaire. Increased anterior cingulate cortex-medial temporal lobe connectivity correlated with increased scores on the self-compassion questionnaire. Post-acute neural changes predicted sustained elevations in nonjudging 2 months later. Conclusions: These results support the involvement of glutamate neurotransmission in the effects of psychedelics in humans. They further suggest that neurometabolic changes in the posterior cingulate cortex, a key region within the default mode network, and increased connectivity between the anterior cingulate cortex and medial temporal lobe structures involved in emotion and memory potentially underlie the post-acute psychological effects of ayahuasca.
Overview
CoChat Summary
## TL;DR
In 16 healthy volunteers, a single ayahuasca dose was followed within 24 hours by posterior cingulate cortex neurometabolic decreases and increased functional connectivity between cingulate and limbic/default-mode-related regions. These post-acute neural changes were associated with higher mindfulness/self-compassion scores, with some correlations persisting at 2 months.
## Key findings
- In the posterior cingulate cortex (PCC), post-acute spectroscopy showed significant decreases in creatine (Cr) and N-acetylaspartate+N-acetylaspartylglutamate (NAA-NAAG), and a decrease in glutamate+glutamine (Glx) that was significant before correction but only marginal after FDR correction (P=.041; FDR P=.068).
- Functional connectivity increased post-acute between the PCC and anterior cingulate cortex (ACC), and between the ACC and limbic structures in the right medial temporal lobe; no areas showed decreased connectivity in the second-level analysis.
- Mindfulness-related scores increased post-acute: FFMQ nonjudging [t(15) = -2.92, P=.011, FDR=.021], nonreacting [t(15) = -2.61, P=.020, FDR=.031], EQ [t(15) = -3.58, P=.003, FDR=.011], Mindsens [t(15) = -3.63, P=.002, FDR=.011], and self-compassion [t(15) = -3.00, P=.009, FDR=.020].
- Exploratory correlations linked PCC Glx decreases with nonjudging increases (n=12; r=-0.589; P=.044), and ACC connectivity increases with nonjudging, nonreacting, and self-compassion scores; at 2 months, PCC Glx decreases and ACC connectivity increases still correlated with nonjudging change.
## Methods
- Open-label, uncontrolled pre/post study of 16 healthy volunteers (6 females) with prior ayahuasca experience; exclusion criteria included psychiatric disorders, substance dependence, significant illness, and pregnancy.
- Participants completed MRI-based assessments before ayahuasca and within 24 hours after intake, plus a 2-month questionnaire follow-up for 14/16 participants.
- Main analyses included repeated-measures ANOVA for MR spectroscopy metabolites, paired-samples t tests for mindfulness scores, and seed-to-voxel resting-state functional connectivity analyses with paired-samples t tests; correlations were exploratory and uncorrected for multiple comparisons.
## Limitations
- The paper states the study was small, open-label, and uncontrolled, with no placebo or time-effect control; it also recommends larger samples and double-blind, placebo-controlled designs.
- The paper states Glx quantification was available only in a smaller subset, and that the correlation analyses were exploratory and should be interpreted with caution.
- Evident from the text: all participants had prior ayahuasca experience and baseline mindfulness scores were already high, which may limit generalizability and create ceiling effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 46 Not checked · 97 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Connectivity was increased between the posterior cingulate cortex and the anterior cingulate cortex”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Abstract > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Post-acute neural changes predicted sustained elevations in nonjudging 2 months later.”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Abstract > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and between the anterior cingulate cortex and limbic structures in the right medial temporal lobe.”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Abstract > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Increased anterior cingulate cortex-medial temporal lobe connectivity correlated with increased scores on the self-compassion questionnaire.”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Glutamate+glutamine reductions correlated with increases in the “nonjudging” subscale of the Five Facets Mindfulness Questionnaire.”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
68 more claims
Create a free account to see all 143 claims and to verify the 77 references still open.
- The quote only partly states this claim. 2
- It may state two separate claims as one. 36
- Probably not a substantial claim. 50
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In the field of psychedelic neuroscience, reduced mPFC-PCC connectivity as well as DMN deactivation and disintegration have been demonstrated post-acutely after the administration of psilocybin, LSD and ayahuasca (45, 46, 57), while long-term ayahuasca users demonstrated thinning of the PCC (117).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [57]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, several studies have found positive associations between ayahuasca use and emotional acceptance processes, which appears to support the acute processing of previously avoided emotions and use of healthy emotion regulation strategies (Domínguez-Clavé et al., 2019; Franquesa et al., 2018; Sampedro et al., 2017; Soler et al., 2016, 2018).”
From Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca (2022) · cites this paper as Sampedro et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies have also demonstrated the capacity of various psychedelics to enhance trait mindfulness post-acutely, even in the absence of a theoretical or practical context of mindfulness training, evidencing a complementary relationship between mindfulness-training and psychedelics (40, 52, 56–59).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, enhanced acceptance towards present-moment thoughts and emotions has been observed post-acutely following the administration of ayahuasca and 5-MeO-DMT, which was maintained for up to 1 month (40, 52, 56–59).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Spontaneous enhancements in trait mindfulness have also been reported following the administration of various psychedelics, even outside of a mindfulness-enhancing context (40, 52, 56–59).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [57]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Statistics that don’t add up
Each reported p-value recomputed from its test statistic and degrees of freedom.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“F(1,12)=3.88, P=.075”
§ Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities > Results > MR Spectroscopy: Neurometabolite Assessment
Reported p = .075 · recomputed p = .072
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Doesn’t add upF(1, 12) = 3.88reported p = .075 · recomputed p = .072
“F(1,12)=3.88, p = .075”
- Not confirmedF(4, 48) = 0.55reported p = .606 · recomputed p = .700
“F(4,48)=0.55, p = .606”
- Not confirmedF(4, 44) = 0.54reported p = .632 · recomputed p = .707
“F(4,44)=0.54, p = .632”
- ConsistentF(4, 44) = 761reported p < .001 · recomputed p < .001
“F(4,44)= 761, p < .001”
- ConsistentF(4, 44) = 4.11reported p < .023 · recomputed p = .006
“F(4,44)=4.11, p < .023”
10 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Citations
Cites
A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190
The human brain is intrinsically organized into dynamic, anticorrelated functional networks
Fox, M. D., Snyder, A. Z., Vincent, J. L., Corbetta, M., Van Essen, D. C., & Raichle, M. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504136102 · Cited by 8,553
Conn : A Functional Connectivity Toolbox for Correlated and Anticorrelated Brain Networks
Whitfield-Gabrieli, S., & Nieto-Castanon, A. (2012) · Brain Connectivity · doi:10.1089/brain.2012.0073 · Cited by 4,885
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Self-citationBrewer, J. A., Worhunsky, P. D., Gray, J. R., Tang, Y.-Y., Weber, J., & Kober, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112029108 · Cited by 1,409 · cited 1×
“, 2014a), a population that also shows a pattern of decreased DMN-TPN anticorrelation (Brewer et al., 2011; Froeliger et al., 2012).”
BackgroundPilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 1×
“Psychedelics are the object of renewed interest as potential therapeutic tools in psychiatry (Sessa, 2005; Vollenweider and Kometer, 2010; Grob et al., 2011).”
BackgroundNeural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172 · cited 1×
“MRS showed neurometabolic changes in the PCC, a region rich in 5-HT2A receptors (Carhart-Harris et al., 2012; Beliveau et al., 2016) and a target region of psychedelics (Palhano-Fontes et al., 2015; Carhart-Harris et al., 2016a; Valle et al., 2016).”
BackgroundSelf-citationPsilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932
Griffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859
Self-citationHamilton, J. P., Furman, D. J., Chang, C., Thomason, M. E., Dennis, E., & Gotlib, I. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.003 · Cited by 823
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723 · cited 3×
“Psychedelics are the object of renewed interest as potential therapeutic tools in psychiatry (Sessa, 2005; Vollenweider and Kometer, 2010; Grob et al., 2011).”
BackgroundDevelopment of Anterior Cingulate Functional Connectivity from Late Childhood to Early Adulthood
Kelly, A. M. C., Di Martino, A., Uddin, L. Q., Shehzad, Z., Gee, D. G., Reiss, P. T., Margulies, D. S., Castellanos, F. X., & Milham, M. P. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn117 · Cited by 572 · cited 1×
“The first seed was placed in the dorsal ACC (dACC) at MNI coordinates x = 5, y = 14, z = 42, over BA 32, a subregion of the ACC involved in executive top-down control, and positive task activation (Kelly et al., 2009).”
MethodFales, C. L., Barch, D. M., Rundle, M. M., Mintun, M. A., Snyder, A. Z., Cohen, J. D., Mathews, J., & Sheline, Y. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.012 · Cited by 517
Increased global functional connectivity correlates with LSD-induced ego dissolution
Tagliazucchi, E., Roseman, L., Kaelen, M., Orban, C., Muthukumaraswamy, S. D., Murphy, K., Laufs, H., Leech, R., McGonigle, J., Crossley, N., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.02.010 · Cited by 503 · cited 1×
“While DMN and TPN activity are typically anticorrelated (Fox et al., 2005), psilocybin and LSD acutely increase DMN-TPN connectivity (Carhart-Harris et al., 2013), and general inter-network connectivity (Roseman et al., 2014; Tagliazucchi et al., 2016).”
BackgroundSelf-citationVogt, B. A., & Laureys, S. (2005) · Progress in Brain Research · doi:10.1016/s0079-6123(05)50015-3 · Cited by 498
Rae, C. D. (2014) · Neurochemical Research · doi:10.1007/s11064-013-1199-5 · Cited by 496
Osório, F. D. L., Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1496 · Cited by 488
Self-citationSanches, R. F., de Lima Osório, F., dos Santos, R. G., Macedo, L. R. H., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A. S., & Hallak, J. E. C. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000436 · Cited by 466
Self-citationPalhano-Fontes, F., Andrade, K. C., Tofoli, L. F., Santos, A. C., Crippa, J. A. S., Hallak, J. E. C., Ribeiro, S., & de Araujo, D. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118143 · Cited by 454
Self-citationAcute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., Müller, F., Borgwardt, S., & Liechti, M. E. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.015 · Cited by 411
McKenna, D. J., Towers, G. H. N., & Abbott, F. (1984) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(84)90003-5 · Cited by 398
Enhanced repertoire of brain dynamical states during the psychedelic experience
Tagliazucchi, E., Carhart‐Harris, R., Leech, R., Nutt, D., & Chialvo, D. R. (2014) · Human Brain Mapping · doi:10.1002/hbm.22562 · Cited by 397
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390
Self-citationA High-Resolution In Vivo Atlas of the Human Brain's Serotonin System
Beliveau, V., Ganz, M., Feng, L., Ozenne, B., Højgaard, L., Fisher, P. M., Svarer, C., Greve, D. N., & Knudsen, G. M. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2830-16.2016 · Cited by 368
Kometer, M., Schmidt, A., Jancke, L., & Vollenweider, F. X. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3007-12.2013 · Cited by 355
Garcia-Campayo, J., Navarro-Gil, M., Andrés, E., Montero-Marin, J., López-Artal, L., & Demarzo, M. M. (2014) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-12-4 · Cited by 306
Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001) · Psychopharmacology · doi:10.1007/s002130000606 · Cited by 303
Self-citationBhagwagar, Z., Wylezinska, M., Jezzard, P., Evans, J., Ashworth, F., Sule, A., Matthews, P. M., & Cowen, P. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.048 · Cited by 303
LSD‐induced entropic brain activity predicts subsequent personality change
Lebedev, A. V., Kaelen, M., Lövdén, M., Nilsson, J., Feilding, A., Nutt, D. J., & Carhart‐Harris, R. L. (2016) · Human Brain Mapping · doi:10.1002/hbm.23234 · Cited by 303
Self-citationThe paradoxical psychological effects of lysergic acid diethylamide LSD
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016) · Psychological Medicine · doi:10.1017/s0033291715002901 · Cited by 293
Self-citationMangia, S., Tkáč, I., Gruetter, R., Van de Moortele, P.-F., Maraviglia, B., & Uğurbil, K. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600401 · Cited by 285
Roseman, L., Leech, R., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00204 · Cited by 272
Self-citationCebolla, A., García-Palacios, A., Soler, J., Guillen, V., Baños, R., & Botella, C. (2012) · The European Journal of Psychiatry · doi:10.4321/s0213-61632012000200005 · Cited by 263 · cited 12×
“Assessment Instruments and Statistical Analysis Scores on mindfulness facets were assessed before and after ayahuasca intake using the Spanish versions of the following instruments: (1) the Five Facet Mindfulness Questionnaire (FFMQ) (Cebolla et al., 2012); (2) the Experiences Questionnaire (EQ) (Soler et al., 2014b);…”
MethodInfluentialSelf-citationFunctional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis
Carhart-Harris, R. L., Leech, R., Erritzoe, D., Williams, T. M., Stone, J. M., Evans, J., Sharp, D. J., Feilding, A., Wise, R. G., & Nutt, D. J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs117 · Cited by 256 · cited 1×
“, 2005), psilocybin and LSD acutely increase DMN-TPN connectivity (Carhart-Harris et al., 2013), and general inter-network connectivity (Roseman et al.”
BackgroundSelf-citationLSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S., & Liechti, M. E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.82 · Cited by 247
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
Riba, J., Romero, S., Grasa, E., Mena, E., Carrió, I., & Barbanoj, M. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0358-7 · Cited by 241 · cited 1×
“On the other hand, radiotracer data shows increased blood flow in the anterior cingulate cortex (ACC) and in the insula, amygdala, and hippocampus, brain areas involved in cognitive control, emotion, and memory (Riba et al., 2006).”
BackgroundSelf-citationSeeing with the eyes shut: neural basis of enhanced imagery following ayahuasca ingestion.
de Araujo, D. B., Ribeiro, S., Cecchi, G. A., Carvalho, F. M., Sanchez, T. A., Pinto, J. P., de Martinis, B. S., Crippa, J. A., Hallak, J. E. C., & Santos, A. C. (2012) · Human Brain Mapping · doi:10.1002/hbm.21381 · Cited by 239
Self-citationMoreno, J. L., Holloway, T., Albizu, L., Sealfon, S. C., & González-Maeso, J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.046 · Cited by 234
Ayahuasca: pharmacology, neuroscience and therapeutic potential
Domínguez-Clavé, E., Soler, J., Elices, M., Pascual, J. C., Álvarez, E., de la Fuente Revenga, M., Friedlander, P., Feilding, A., & Riba, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.002 · Cited by 226
Self-citationThe experimental use of psychedelic (LSD) psychotherapy.
Pahnke, W. N. (1970) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1970.03170240060010 · Cited by 220 · cited 1×
“In fact, early researchers coined the term “after-glow” to designate a positive post-acute phase of psychedelic drug effects characterized by elevated mood and openness (Pahnke et al., 1970).”
BackgroundBouso, J. C., Palhano-Fontes, F., Rodríguez-Fornells, A., Ribeiro, S., Sanches, R., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., & Riba, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.008 · Cited by 218 · cited 1×
“PCC thinning was inversely correlated with increased self-transcendence, a personality trait closely related to openness (Bouso et al., 2015).”
BackgroundSelf-citationSoler, J., Elices, M., Franquesa, A., Barker, S., Friedlander, P., Feilding, A., Pascual, J. C., & Riba, J. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4162-0 · Cited by 209
Self-citationLi, B. S. Y., Wang, H., & Gonen, O. (2003) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(03)00181-4 · Cited by 202
Valle, M., Maqueda, A. E., Rabella, M., Rodríguez-Pujadas, A., Antonijoan, R. M., Romero, S., Alonso, J. F., Mañanas, M. À., Barker, S., Friedlander, P., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.012 · Cited by 173
Self-citationEffects of serotonin 2A/1A receptor stimulation on social exclusion processing
Preller, K. H., Pokorny, T., Hock, A., Kraehenmann, R., Stämpfli, P., Seifritz, E., Scheidegger, M., & Vollenweider, F. X. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524187113 · Cited by 169
Doll, A., Hölzel, B. K., Boucard, C. C., Wohlschläger, A. M., & Sorg, C. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00461 · Cited by 165
Psychedelic drugs and mystical experience.
Pahnke, W. N. (1969) · PubMed · Cited by 138
Relationship between meditative practice and self-reported mindfulness: the MINDSENS composite index
Soler, J., Cebolla, A., Feliu-Soler, A., Demarzo, M. M. P., Pascual, J. C., Baños, R., & García-Campayo, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086622 · Cited by 138
Self-citationScruggs, J. L., Schmidt, D. E., & Deutch, A. Y. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00547-0 · Cited by 138
Riba, J., Anderer, P., Jané, F., Saletu, B., & Barbanoj, M. J. (2004) · Neuropsychobiology · doi:10.1159/000077946 · Cited by 130
Self-citationMuschamp, J. W., Regina, M. J., Hull, E. M., Winter, J. C., & Rabin, R. A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.044 · Cited by 129
Winkelman, M. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107120011 · Cited by 126 · cited 1×
“This post-acute phase has been reported to extend between 6 and 8 weeks after the acute psychedelic effects and characterized as a window of opportunity for therapeutic intervention (Halpern, 1996; Winkelman, 2014).”
BackgroundSzabo, A., Kovacs, A., Riba, J., Djurovic, S., Rajnavolgyi, E., & Frecska, E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00423 · Cited by 121
Self-citationFroeliger, B., Garland, E. L., Kozink, R. V., Modlin, L. A., Chen, N.-K., McClernon, F. J., Greeson, J. M., & Sobin, P. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/680407 · Cited by 116 · cited 1×
“, 2014a), a population that also shows a pattern of decreased DMN-TPN anticorrelation (Brewer et al., 2011; Froeliger et al., 2012).”
BackgroundAcute biphasic effects of ayahuasca.
Schenberg, E. E., Alexandre, J. F. M., Filev, R., Cravo, A. M., Sato, J. R., Muthukumaraswamy, S. D., Yonamine, M., Waguespack, M., Lomnicka, I., Barker, S. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137202 · Cited by 111 · cited 1×
“…studies show a suppression of the inhibitory alpha rhythm in the occipital and parietal cortex, including the posterior cingulate cortex (PCC) (Schenberg et al., 2015; Valle et al., 2016), a key node of the default mode network (DMN) with a prominent role in self-reflection and consciousness…”
BackgroundSelf-citationGroup II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice
Kłodzińska, A., Bijak, M., Tokarski, K., & Pilc, A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00845-6 · Cited by 103
Can psychedelics have a role in psychiatry once again?
Sessa, B. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.6.457 · Cited by 98
Riba, J., McIlhenny, E. H., Bouso, J. C., & Barker, S. A. (2015) · Drug Testing and Analysis · doi:10.1002/dta.1685 · Cited by 97
Self-citationSoler, J., Franquesa, A., Feliu-Soler, A., Cebolla, A., García-Campayo, J., Tejedor, R., Demarzo, M., Baños, R., Pascual, J. C., & Portella, M. J. (2014) · Behavior Therapy · doi:10.1016/j.beth.2014.05.004 · Cited by 92 · cited 3×
“…using the Spanish versions of the following instruments: (1) the Five Facet Mindfulness Questionnaire (FFMQ) (Cebolla et al., 2012); (2) the Experiences Questionnaire (EQ) (Soler et al., 2014b); and (3) the short version of the SelfCompassion (SC) questionnaire (Garcia-Campayo et al., 2014).”
BackgroundMethodSelf-citationFrecska, E., Móré, C. E., Vargha, A., & Luna, L. E. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.703099 · Cited by 87 · cited 1×
“These effects could explain increased phosphenes or “entoptic activity” persisting days after ayahuasca use (Frecska et al., 2012).”
BackgroundSelf-citationRegions and Subregions of the Cingulate Cortex
Vogt, B. A. (2009) · Cingulate Neurobiology and Disease · doi:10.1093/oso/9780198566960.003.0001 · Cited by 69
Montero-Marin, J., Puebla-Guedea, M., Herrera-Mercadal, P., Cebolla, A., Soler, J., Demarzo, M., Vazquez, C., Rodríguez-Bornaetxea, F., & García-Campayo, J. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.01935 · Cited by 68
Self-citationCarbonaro, T. M., Eshleman, A. J., Forster, M. J., Cheng, K., Rice, K. C., & Gatch, M. B. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3658-3 · Cited by 66
McIlhenny, E. H., Pipkin, K. E., Standish, L. J., Wechkin, H. A., Strassman, R. J., & Barker, S. A. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.10.088 · Cited by 64
Self-citationThe Use of Hallucinogens in the Treatment of Addiction
Halpern, J. H. (1996) · Addiction Research · doi:10.3109/16066359609010756 · Cited by 63
Abdallah, C. G., Niciu, M. J., Fenton, L. R., Fasula, M. K., Jiang, L., Black, A., Rothman, D. L., Mason, G. F., & Sanacora, G. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000361078 · Cited by 61
Terhune, D. B., Murray, E., Near, J., Stagg, C. J., Cowey, A., & Cohen Kadosh, R. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv015 · Cited by 50
Vaquero, L., Cámara, E., Sampedro, F., Pérez de los Cobos, J., Batlle, F., Fabregas, J. M., Sales, J. A., Cervantes, M., Ferrer, X., Lazcano, G., et al. (2017) · Addiction Biology · doi:10.1111/adb.12356 · Cited by 49
Self-citationDixon, M. L., Fox, K. C. R., & Christoff, K. (2014) · Brain Research · doi:10.1016/j.brainres.2014.05.012 · Cited by 47
Huang, Z., Davis Iv, H. H., Yue, Q., Wiebking, C., Duncan, N. W., Zhang, J., Wagner, N.-F., Wolff, A., & Northoff, G. (2015) · Human Brain Mapping · doi:10.1002/hbm.22841 · Cited by 43 · cited 1×
“Cortical glutamate levels increase in periods of external perceptual stimulation or during active cognitive tasks, while they fall below baseline levels during stimulation- or task-free periods (Mangia et al., 2007; Huang et al., 2015; Terhune et al., 2015).”
BackgroundExperience of Treatment with Ayahuasca for Drug Addiction in the Brazilian Amazon
Fernández, X., & Fábregas, J. M. (2013) · Springer eBooks · doi:10.1007/978-3-642-40426-9_10 · Cited by 37
The effects of psychedelic (LSD) therapy on values, personality, and behavior.
Savage, C., Fadiman, J., Mogar, R. E., & Allen, M. H. (1966) · PubMed · Cited by 33
Research works printed but not linked: 1
- 2014, Assessing decentering: validation, psychometric properties and clinical usefulness of the Experiences Questionnaire in a Spanish sample, Behav Ther, 45, 863, 10.1016/j.beth.2014.05.004 · DOI · Paper page
Cited by
REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13282-7 · Cited by 587
The entropic brain - revisited
Carhart-Harris, R. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.010 · Cited by 522
Emotions and brain function are altered up to one month after a single high dose of psilocybin.
Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J., & Griffiths, R. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-59282-y · Cited by 375
Doss, M. K., Považan, M., Rosenberg, M. D., Sepeda, N. D., Davis, A. K., Finan, P. H., Smith, G. S., Pekar, J. J., Barker, P. B., Griffiths, R. R., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01706-y · Cited by 356
Metadata
- Authors
- Sampedro, F., de la Fuente Revenga, M., Valle, M., Roberto, N., Domínguez-Clavé, E., Elices, M., Luna, L. E., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., Friedlander, P., Barker, S. A., Álvarez, E., Soler, J., Pascual, J. C., Feilding, A., & Riba, J.
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- ORCID
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-06-13
- Volume
- 20
- Issue
- 9
- Pages
- 698-711
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC5581489
- OpenAlex
- W2616273018
- Semantic Scholar
- b0995e4954d6fef2bf65bfd7d47bd21f6087bd23
- Cited by
- 200
- References
- 74
- Citations by year
- 2026: 16 · 2025: 19 · 2024: 26 · 2023: 35 · 2022: 27 · 2021: 32 · 2020: 18 · 2019: 14 · 2018: 11 · 2017: 1
- FWCI
- 14.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, other-oa)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc)
- Funders
- Beckley Foundation
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Keywords
- ayahuasca, psychedelics, mindfulness, non-judgment, self-compassion, posterior cingulate cortex, anterior cingulate cortex, medial temporal lobe, default mode network, glutamate, neurometabolites, functional connectivity, N,N-dimethyltryptamine, harmala alkaloids, antidepressant effects
- MeSH terms
- Adult, Aspartic Acid, Brain Mapping, Cerebral Cortex, Female, Follow-Up Studies, Hallucinogens, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Magnetic Resonance Spectroscopy, Surveys and Questionnaires, Time Factors, Glutamic Acid, Imaging, Three-Dimensional, Banisteriopsis, Healthy Volunteers, Mindfulness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.